the treatment of 311 cells , a pluripotent mouse teratocarcinoma cell line , with a new type of inducer , 3,5-di-tert-butylchalcone 4'-carboxylic acid ( ch55 ) , results in the suppression of the c-mos gene , accompanied by early marker changes associated with cell differentiation , i.e. , the enhanced secretion of plasminogen activator and the decrease in peanut agglutinin receptors and glucose transport .
C0007634
the
C0007589
cell differentiation